`

Cyclenium Pharma Inc

Biotechnology Research

Specialities :
Drug discovery
Oncology
Inflammation
And anti-infectives
revenue-icon Revenue
1M - 10M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Cyclenium Pharma Inc

What does Cyclenium pharma inc do?+

Cyclenium Pharma is a growing pharmaceutical R&D company exploiting its next generation CMRTTM macrocyclic drug discovery technology to identify novel small molecule therapeutics for difficult disease targets in areas of unsatisfied medical need. Cyclenium is creating value through progression of internal programs in oncology, infectious diseases and inflammation/pain. In addition, Cyclenium is providing its extensive experience and exploring its CMRT-based QUESTTM screening library in risk-sharing partnerships with leading academic and research driven non-profit organizations as well as collaborations with innovative pharmaceutical and biotechnology companies world-wide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. As part of...

What are Cyclenium pharma inc's specialties? +

Drug discovery,oncology,inflammation,and anti-infectives

What is Cyclenium pharma inc's industry? +

Cyclenium pharma inc operates in the Biotechnology research industry.

What is Cyclenium pharma inc's revenue? +

Cyclenium pharma inc's revenue is 1m - 10m

What is Cyclenium pharma inc's company size? +

Cyclenium pharma inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.